Diaphragmatic Ultrasonography in the respiratory assessment of Facioscapulohumeral Muscular Dystrophy (FSHD): a promising approach for management and longitudinal follow-up
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingA Real-life experience with Eculizumab and Efgartigimod in generalized Myasthenia Gravis patients
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingLongitudinal echocardiographic measures in Becker muscular dystrophy
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingOptimization of a screening assay for antibody-mediated complement activation (ACA) in autoimmune neurological disorders
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingFrequency of LRP4 antibodies in a consecutive cohort of suspected Myasthenia Gravis patients.
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingThe DMD Hub Central Recruitment Database, a model for effective recruitment to Rare Disease clinical trials
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingNovel biomarkers for limb-girdle muscular dystrophy associated to CAPN3 mutation
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingEFFECTIVENESS OF THYMECTOMY IN JUVENILE MYASTHENIA GRAVIS: PRELIMINARY RESULTS OF A15-YEAR FOLLOW UP STUDY
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingA familiar case of ptosis and dysphagia with facial dysmofisms due to a novel KMT2D gene mutation.
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingSEGRETERIA NAZIONALE AIM
Seguici sulle nostre pagine social
SEGRETERIA ORGANIZZATIVA FIRST CLASS
First Class S.r.l. Meetings and Conferences